Warning: This security is no longer trading.
IPO has been postponed for the moment
Alzheon, Inc. (ALZH): Price and Financial Metrics
ALZH Price/Volume Stats
| Current price | $0.00 | 52-week high | $0.00 |
| Prev. close | $0.00 | 52-week low | $0.00 |
| Day low | $0.00 | Volume | 0 |
| Day high | $0.00 | Avg. volume | 0 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | N/A |
ALZH Stock Price Chart Interactive Chart >
Alzheon, Inc. (ALZH) Company Bio
Alzheon, Inc. operates as a clinical stage biopharmaceutical company in the United States and internationally. The company’s lead product is ALZ-801, an orally administered inhibitor of beta amyloid misfolding, which is in Phase III clinical trial for treating Alzheimer’s disease and other neurological disorders. Its lead preclinical candidate compound includes ALZ-1903, a chemical entity and potent inhibitor of beta amyloid misfolding. The company was founded in 2013 and is based in Framingham, Massachusetts.
ALZH Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...